 The study demonstrated that optimized DNA vaccines against Lassa fever and Ebola hemorrhagic fever viruses were protective individually in guinea pig and non-human primate models, and also protected against both viruses if exposures were temporarily separated. This article was authored by Kathleen A. Cashman, Erica Wilkinson, Suzanne E. Woollan and others.